Hans Loibner, Chief Executive Officer of APEIRON Biologics holds a PhD in Organic Chemistry from the University of Vienna. More than 20 years in R&D management at Sandoz/Novartis; Founded and developed the biotech company Igeneon (cancer immunotherapy).
cancer immunotherapy